Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the most undervalued large cap stocks to buy according to analysts.

The FDA has granted accelerated approval to Datroway for adults with previously-treated, locally advanced or metastatic EGFR-mutated NSCLC.

New trustee report reveals accelerated timeline for Social Security and Medicare insolvency, with potential 23% benefit ...

Denali Therapeutics, Inc. DNLI announced that the FDA has accepted for review its biologics license application (BLA) for ...

Crédit Agricole Assurances announces the launch of an accelerated bookbuilding offering of its whole stake in FDJ United ...

A new accelerated training program for Colorado residents gives people the opportunity to get jobs in the clean energy sector ...

A Senate committee will vote this week on whether to advance the nomination of Susan Monarez, President Donald Trump’s pick ...

Pacific Bay is pleased to announce that Elton Pereira, formerly vice-president, exploration, has transitioned to the role of country manager, Brazil. This change reflects the company's strategic focus ...